Valeant names new CEO as Sprout shareholders still unhappy
April 25, 2016 at 14:08 PM EDT
As Valeant Pharmaceuticals International, Inc. (NYSE: VRX) faces waves of criticism, not least of which coming from former investors in Raleigh-based Sprout Pharmaceuticals, the pharma giant has named Joseph C...